Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05211934
Other study ID # 20220101
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 1, 2022
Est. completion date July 1, 2024

Study information

Verified date January 2022
Source Beijing Anzhen Hospital
Contact Jun Ma
Phone 13370103571
Email majun7689@163.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Delirium is an acute brain lesion characterized by abnormalities of consciousness, attention, cognition and sensation. Many brain diseases such as stroke, traumatic brain injury and intracranial hypertension can lead to cardiac insufficiency, arrhythmia and heart failure. The incidence of postoperative delirium in patients undergoing cardiac surgery is high. Postoperative delirium is a manifestation of brain function injury. The effect of postoperative delirium on postoperative cardiac function in patients undergoing cardiac surgery is worthy of further discussion.


Recruitment information / eligibility

Status Recruiting
Enrollment 300
Est. completion date July 1, 2024
Est. primary completion date July 1, 2024
Accepts healthy volunteers No
Gender All
Age group 60 Years to 75 Years
Eligibility Inclusion Criteria: - Patients undergoing valvular surgery - Age between 60 to 75 Exclusion Criteria: - Have a history of cerebral infarction before operation - Cardiac function was seriously impaired before surgery - Neuropsychiatric disorders were present before surgery

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No intervention
No intervention

Locations

Country Name City State
China Anzhen hospital, Beijing Beijing Beijing

Sponsors (1)

Lead Sponsor Collaborator
Beijing Anzhen Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary heart function Doses of norepinephrine, epinephrine, dopamine, dobutamine and vasopressin up to 60 days
See also
  Status Clinical Trial Phase
Completed NCT00890838 - Preoperative Intravenous Omega 3 Fatty Acids Administration in Valvular Surgery Patients Phase 4